CN114807086B - Holliday connector dissociating enzyme DrRuvC and encoding gene and application thereof - Google Patents
Holliday connector dissociating enzyme DrRuvC and encoding gene and application thereof Download PDFInfo
- Publication number
- CN114807086B CN114807086B CN202210399536.XA CN202210399536A CN114807086B CN 114807086 B CN114807086 B CN 114807086B CN 202210399536 A CN202210399536 A CN 202210399536A CN 114807086 B CN114807086 B CN 114807086B
- Authority
- CN
- China
- Prior art keywords
- drruvc
- holliday
- dna
- enzyme
- connector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 47
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 47
- 108090000623 proteins and genes Proteins 0.000 title abstract description 44
- 238000006243 chemical reaction Methods 0.000 claims abstract description 57
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 55
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 29
- 239000011780 sodium chloride Substances 0.000 claims abstract description 27
- 239000000758 substrate Substances 0.000 claims description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 33
- 239000007983 Tris buffer Substances 0.000 claims description 22
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 22
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 claims description 21
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 18
- 239000012089 stop solution Substances 0.000 claims description 16
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 11
- 239000004202 carbamide Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 238000010791 quenching Methods 0.000 claims description 9
- 230000000171 quenching effect Effects 0.000 claims description 9
- 239000003292 glue Substances 0.000 claims description 6
- 150000002500 ions Chemical class 0.000 claims description 6
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 6
- 108010067770 Endopeptidase K Proteins 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000003197 catalytic effect Effects 0.000 abstract description 15
- 238000003776 cleavage reaction Methods 0.000 abstract description 12
- 230000007017 scission Effects 0.000 abstract description 12
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 abstract description 6
- 241000192091 Deinococcus radiodurans Species 0.000 abstract description 5
- 108091036078 conserved sequence Proteins 0.000 abstract description 4
- 229940104302 cytosine Drugs 0.000 abstract description 3
- 108020004414 DNA Proteins 0.000 description 83
- 102000004169 proteins and genes Human genes 0.000 description 32
- 230000000694 effects Effects 0.000 description 23
- 239000000047 product Substances 0.000 description 19
- 238000010494 dissociation reaction Methods 0.000 description 16
- 230000005593 dissociations Effects 0.000 description 16
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 14
- 238000012216 screening Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 239000000499 gel Substances 0.000 description 10
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 239000000872 buffer Substances 0.000 description 7
- 239000013604 expression vector Substances 0.000 description 7
- 229910052759 nickel Inorganic materials 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 229920002971 Heparan sulfate Polymers 0.000 description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000001976 enzyme digestion Methods 0.000 description 5
- 239000002808 molecular sieve Substances 0.000 description 5
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 3
- 108091064358 Holliday junction Proteins 0.000 description 3
- 102000039011 Holliday junction Human genes 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 230000004543 DNA replication Effects 0.000 description 2
- 240000000220 Panda oleosa Species 0.000 description 2
- 235000016496 Panda oleosa Nutrition 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- 239000012505 Superdex™ Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- MPBRYMWMMKKRGC-UHFFFAOYSA-M carbocyanin DBTC Chemical compound [Br-].C1=CC=CC2=C([N+](=C(C=C(C)C=C3N(C4=C5C=CC=CC5=CC=C4S3)CC)S3)CC)C3=CC=C21 MPBRYMWMMKKRGC-UHFFFAOYSA-M 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 150000004713 phosphodiesters Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- COEXAQSTZUWMRI-STQMWFEESA-N (2s)-1-[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([C@H](N)C(=O)NCC(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 COEXAQSTZUWMRI-STQMWFEESA-N 0.000 description 1
- LGFCAXJBAZESCF-ACZMJKKPSA-N Ala-Gln-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O LGFCAXJBAZESCF-ACZMJKKPSA-N 0.000 description 1
- HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 1
- YXXPVUOMPSZURS-ZLIFDBKOSA-N Ala-Trp-Leu Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](C)N)=CNC2=C1 YXXPVUOMPSZURS-ZLIFDBKOSA-N 0.000 description 1
- VBFJESQBIWCWRL-DCAQKATOSA-N Arg-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VBFJESQBIWCWRL-DCAQKATOSA-N 0.000 description 1
- AYZAWXAPBAYCHO-CIUDSAMLSA-N Asn-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N AYZAWXAPBAYCHO-CIUDSAMLSA-N 0.000 description 1
- VSMYBNPOHYAXSD-GUBZILKMSA-N Asp-Lys-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O VSMYBNPOHYAXSD-GUBZILKMSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- XZKJEOMFLDVXJG-KATARQTJSA-N Cys-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)N)O XZKJEOMFLDVXJG-KATARQTJSA-N 0.000 description 1
- SDSMVVSHLAAOJL-UKJIMTQDSA-N Gln-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)N SDSMVVSHLAAOJL-UKJIMTQDSA-N 0.000 description 1
- MTAOBYXRYJZRGQ-WDSKDSINSA-N Glu-Gly-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MTAOBYXRYJZRGQ-WDSKDSINSA-N 0.000 description 1
- WNRZUESNGGDCJX-JYJNAYRXSA-N Glu-Leu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WNRZUESNGGDCJX-JYJNAYRXSA-N 0.000 description 1
- NJCALAAIGREHDR-WDCWCFNPSA-N Glu-Leu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NJCALAAIGREHDR-WDCWCFNPSA-N 0.000 description 1
- NTHIHAUEXVTXQG-KKUMJFAQSA-N Glu-Tyr-Arg Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O NTHIHAUEXVTXQG-KKUMJFAQSA-N 0.000 description 1
- JXYMPBCYRKWJEE-BQBZGAKWSA-N Gly-Arg-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O JXYMPBCYRKWJEE-BQBZGAKWSA-N 0.000 description 1
- SXJHOPPTOJACOA-QXEWZRGKSA-N Gly-Ile-Arg Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SXJHOPPTOJACOA-QXEWZRGKSA-N 0.000 description 1
- PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 1
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 1
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 1
- BZKDJRSZWLPJNI-SRVKXCTJSA-N His-His-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O BZKDJRSZWLPJNI-SRVKXCTJSA-N 0.000 description 1
- MIHTTYXBXIRRGV-AVGNSLFASA-N His-Met-Arg Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N MIHTTYXBXIRRGV-AVGNSLFASA-N 0.000 description 1
- NPROWIBAWYMPAZ-GUDRVLHUSA-N Ile-Asp-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N NPROWIBAWYMPAZ-GUDRVLHUSA-N 0.000 description 1
- JLWLMGADIQFKRD-QSFUFRPTSA-N Ile-His-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CN=CN1 JLWLMGADIQFKRD-QSFUFRPTSA-N 0.000 description 1
- KUEVMUXNILMJTK-JYJNAYRXSA-N Leu-Gln-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KUEVMUXNILMJTK-JYJNAYRXSA-N 0.000 description 1
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 1
- KXODZBLFVFSLAI-AVGNSLFASA-N Leu-His-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CN=CN1 KXODZBLFVFSLAI-AVGNSLFASA-N 0.000 description 1
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 1
- IOQWIOPSKJOEKI-SRVKXCTJSA-N Lys-Ser-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IOQWIOPSKJOEKI-SRVKXCTJSA-N 0.000 description 1
- PHWSCIFNNLLUFJ-NHCYSSNCSA-N Met-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCSC)N PHWSCIFNNLLUFJ-NHCYSSNCSA-N 0.000 description 1
- LRALLISKBZNSKN-BQBZGAKWSA-N Met-Gly-Ser Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LRALLISKBZNSKN-BQBZGAKWSA-N 0.000 description 1
- PHKBGZKVOJCIMZ-SRVKXCTJSA-N Met-Pro-Arg Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PHKBGZKVOJCIMZ-SRVKXCTJSA-N 0.000 description 1
- LPNWWHBFXPNHJG-AVGNSLFASA-N Met-Val-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN LPNWWHBFXPNHJG-AVGNSLFASA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- LLGTYVHITPVGKR-RYUDHWBXSA-N Phe-Gln-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O LLGTYVHITPVGKR-RYUDHWBXSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- SQBLRDDJTUJDMV-ACZMJKKPSA-N Ser-Glu-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQBLRDDJTUJDMV-ACZMJKKPSA-N 0.000 description 1
- IOVBCLGAJJXOHK-SRVKXCTJSA-N Ser-His-His Chemical compound C([C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 IOVBCLGAJJXOHK-SRVKXCTJSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- ONNSECRQFSTMCC-XKBZYTNZSA-N Thr-Glu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O ONNSECRQFSTMCC-XKBZYTNZSA-N 0.000 description 1
- RIFVTNDKUMSSMN-ULQDDVLXSA-N Tyr-His-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O RIFVTNDKUMSSMN-ULQDDVLXSA-N 0.000 description 1
- KZKMBGXCNLPYKD-YEPSODPASA-N Val-Gly-Thr Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O KZKMBGXCNLPYKD-YEPSODPASA-N 0.000 description 1
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 101150071322 ruvC gene Proteins 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/21—Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
Abstract
The invention discloses a holliday connector dissociating enzyme DrRuvC and a coding gene and application thereof. DrRuvC is derived from deinococcus radiodurans, is in a homodimeric state in solution, can specifically bind to the DNA of the holliday connector, and symmetrically causes single-chain phosphodiester bonds to break at the joint, so that one holliday connector is dissociated into two double-chain DNA with gaps. The holliday linker specifically recognized by the holliday linker contains a conserved sequence of 5'-TC-3' in the connecting junction region, and the enzyme cleavage site is a phosphodiester bond after cytosine. The enzyme prefers 5'- (G/C) TC (G/C) -3' sequence, and the optimal catalytic metal ion is Mn 2+ (2.5-10 mM), the optimal reaction pH is 7.6-8.4, the optimal reaction NaCl concentration is 50-150mM, and the optimal reaction temperature is 40-45 ℃.
Description
Technical Field
The invention belongs to the technical field of biology, relates to a holliday connector dissociating enzyme DrRuvC, and a coding gene and application thereof, in particular to preparation of a novel holliday connector dissociating enzyme (DrRuvC) from deinococcus radiodurans, and relates to a holliday connector DNA conserved sequence characteristic identified by the enzyme and a method for improving enzyme activity.
Background
The holliday linker (Holliday junction resolvase) appears in the late stage of cellular DNA homologous recombination (homologous recombination) and during the back-off of the DNA replication fork (DNA replication fork regression), and its main structure is a four-chain DNA intermediate rich in homologous regions. Holliday linkers in the genome, if not dissociated efficiently, will cause a disturbance in genome replication, and thus, one or more holliday linker dissociases are often encoded in the cell to help maintain stability of the genome and order of cell division.
Researchers have discovered, several years ago, that the protein encoded by the ruvC gene, ecRuvC, in escherichia coli possesses holliday linker dissociating enzyme activity (Saito, a.et al (1995), "Identification of four acidic amino acids that constitute the catalytic center of the RuvC Holliday junction resolvase.,".Proc Natl Acad Sci U S A92 (16):7470-7474). Ec ruvc is a homodimeric structure that favors the recognition of holliday linkers containing the conserved sequence 5'- (a/T) TT (G/C) -3' in the junction region. The ecluvc can cleave the phosphodiester linkage of the single-stranded region (specifically, the phosphodiester linkage after the second thymine) symmetrically at the holliday linker junction, thereby dissociating one holliday linker into two nicked double-stranded DNA.
Most of the currently commercialized holliday linker dissociating enzymes are recombinant e.coli ec ruvc proteins expressed in vitro, such as the recombinant ec ruvc protein sold by abcam corporation (cat No. P0a 814). The eclovc has a limitation in use as a tool enzyme in genetic engineering because it preferentially dissociates hollydi linker containing 5'- (a/T) TT (G/C) -3' and has a weak ability to dissociate hollydi linker containing other sequences.
Disclosure of Invention
The invention aims to provide a novel holliday connector dissociating enzyme (DrRuvC) derived from deinococcus radiodurans, and a coding gene and application thereof.
The above object of the present invention is achieved by the following technical solutions: amplifying a gene fragment encoding DrRuvC from a genome of the deinococcus radiodurans, constructing a DrRuvC expression vector, preparing a DrRuvC protein, verifying the activity of the DrRuvC protease, screening the optimal substrate sequence of the DrRuvC protein, and searching the optimal enzyme activity conditions (optimal metal ion and concentration, optimal pH, optimal NaCl concentration and optimal temperature) of the DrRuvC.
In a first aspect, the present invention provides a hollidar linker dissociating enzyme DrRuvC, the amino acid sequence of which is shown in SEQ No.4.
In a second aspect, the present invention provides a gene encoding the holliday junction dissociating enzyme DrRuvC, the nucleotide sequence of which is shown in SEQ No.3.
In a third aspect, the invention provides an expression vector comprising a gene encoding DrRuvC.
In a fourth aspect, the invention provides the use of the enzyme DrRuvC to a holliday linker comprising a 5'- (G/C) TC (G/C) -3' sequence at the dissociative junction.
In a fifth aspect, the present invention provides a method for the dissociation of the holliday linker, in particular by placing 10 μl of the reaction system at 40-45 ℃ for 30 minutes, followed by two methods for termination and identification of the product as desired: adding an equal volume of stop solution A to stop the reaction, heating at 100 ℃ for 20 minutes, transferring to ice for quenching, and then separating the product by utilizing TBE urea gum; or, adding an equal volume of stop solution B to stop the reaction, and separating the product by using TBE active gel after stopping the reaction at 37 ℃ for 20 minutes.
The 10 μl reaction system contains 1 μM of the enzyme DrRuvC of claim 1, holliday linker substrate containing 5'- (G/C) TC (G/C) -3' sequence at 500nM junction, 50-150mM NaCl, a concentration of metal ion, 20mM Tris pH7.6-8.4, 0.5mM TCEP, 5% glycerol;
the metal ion is Mn or Mg.
Preferably, the stop solution A is 20mM EDTA and 98% formamide.
Preferably, the stop solution B is 20mM EDTA and 10mg/mL proteinase K.
Preferably, when the metal ion is Mn, the concentration of Mn ion in the reaction system is 2.5-10mM.
Preferably, when the metal ion is Mg, the concentration of Mg ion in the reaction system is 20mM.
Preferably, the pH of the reaction system is 8.0.
The beneficial effects of the invention are as follows:
the novel holliday connector dissociating enzyme DrRuvC is derived from deinococcus radiodurans, is in a homodimeric state in a solution, can specifically bind to the DNA of the holliday connector, and symmetrically causes single-chain phosphodiester bond rupture at the joint, so that one holliday connector is dissociated into two double-chain DNAs with gaps. The holliday linker specifically recognized by the holliday linker contains a conserved sequence of 5'-TC-3' in the connecting junction region, and the enzyme cleavage site is a phosphodiester bond after cytosine. The enzyme prefers 5'- (G/C) TC (G/C) -3' sequence, and the optimal catalytic metal ion is Mn 2+ (2.5-10 mM), the optimal reaction pH is 7.6-8.4, the optimal reaction NaCl concentration is 50-150mM, and the optimal reaction temperature is 40-45 ℃.
The novel holliday connector dissociation enzyme DrRuvC disclosed by the invention has the advantages that the preferential substrate sequence is different from that of the existing commercialized holliday connector dissociation enzyme (EcRuvC), the substrate limitation problem of the holliday connector dissociation enzyme is solved, and the novel holliday connector dissociation enzyme has important significance in developing novel molecular biology tool enzymes.
Drawings
FIG. 1 shows the detection of drruvC gene fragments amplified from the genome of P.radiodurans by agarose gel. The amplified target fragment was about 550bp in size.
FIG. 2 is a map of the pET28T-drruvC expression vector after successful construction.
FIG. 3 (A) shows a map of the purified DrRuvC molecular sieve (Superdex 75) with peak positions at 10ml, corresponding molecular weights of about 40-45kDa, and the molecular weight of the DrRuvC monomer at about 20kDa, demonstrating that DrRuvC exists as a homodimer in solution; (B) purity of DrRuvC was checked by 15% SDS-PAGE.
Fig. 4 is a test of the effect of DrRuvC on holliday connector dissociation. Above the picture is the synthetic holliday linker substrate HJ98 used in this experiment, the portion of the substrate sequence that is plotted as a horizontal line being the region of homologous sequence of the holliday linker. The sequence without a frame on the gray background is a specific enzyme digestion sequence of the commercialized EcRuvC enzyme, and the sequence with a frame on the gray background is a specific enzyme digestion sequence of the DrRuvC enzyme prepared in the invention. Because the 5' end of the corresponding sequence in the substrate is provided with a 6-FAM fluorescent group, the enzyme digestion product of the sequence can be detected by a fluorescent glue scanner with corresponding wavelength after being separated by 15% TBE urea glue. Among them, ec ruvc is a recombinant ec ruvc protein sold by abcam corporation as a control. The leftmost lane of the gel is a single-stranded DNAmarker.
Fig. 5 is an analysis of holliday linker dissociation sites by DrRuvC. Based on the results of FIG. 4, a shorter holliday linker substrate (HJ 31) was designed to more precisely locate the DrRuvC cleavage site. The portion of the substrate sequence that is depicted as a horizontal line is the region of homologous sequence of the holliday linker. Because the 5' end of the corresponding sequence in the substrate is provided with a 6-FAM fluorescent group, the enzyme digestion product of the sequence can be detected by a fluorescent glue scanner with corresponding wavelength after being separated by 15% TBE urea glue. Among them, ec ruvc is a recombinant ec ruvc protein sold by abcam corporation as a control. The leftmost lane of the gel is a single-stranded DNAmarker. The position marked by the arrow in the substrate is the cleavage site judged from the glue pattern, wherein the DrRuvC cleavage site is after TC, and the control EcRuvC cleavage site is after TT.
FIG. 6 is a screen for DrRuvC-favored Holiday linker junction region sequences. Four variable bases (N) 1 N 2 N 3 N 4 ) After cleavage of the enzyme with 10% TBE activated gel, the gel was stained with Stains-all dye (Bio-technology), and the results showed that DrRuvC preferentially dissociates the holliday linker containing 5'- (G/C) TC (G/C) -3' sequence at the junction.
FIG. 7 is a screening result of the optimal catalytic metal ions and concentrations in optimizing DrRuvC enzyme activity conditions. (A) DrRuvC at 10mM different metal ions (MgCl 2 、MnCl 2 、CaCl 2 、ZnSO 4 、NiCl 2 、CoCl 2 And CuCl 2 ) Comparison of catalytic efficiency under conditions.(B) DrRuvC is MgCl at various concentrations (0.31, 0.625, 1.25, 2.5, 5, 10, 20 mM) 2 And MnCl 2 Comparison of catalytic efficiency under conditions.
FIG. 8 is the result of screening for optimal pH in optimizing DrRuvC enzymatic activity conditions. Comparison of the catalytic efficiency of DrRuvC at different pH conditions (pH 5.6, 6.0, 6.4, 6.8, 7.2, 7.6, 8.0, 8.4, 8.8, 9.2).
FIG. 9 is a screening result of the optimal NaCl concentration in optimizing the DrRuvC enzyme activity condition. Comparison of catalytic efficiency of DrRuvC at different NaCl concentrations (50, 100, 150, 200, 250, 300, 350, 400, 450, 500 mM).
FIG. 10 is a screening result of the optimal reaction temperature in optimizing DrRuvC enzyme activity conditions. Comparison of the catalytic efficiency of DrRuvC at different temperatures (15 ℃, 20 ℃, 25 ℃, 30 ℃, 35 ℃, 40 ℃, 45 ℃,50 ℃, 55 ℃, 60 ℃).
Detailed Description
In order to make the objects, technical solutions and technical effects of the present invention more apparent, the present invention will be further described in detail with reference to the drawings and examples of the specification. (the DNA sequences according to the examples were all synthesized by Shanghai Jieli, and the reagents and drugs according to the examples were purchased from Shanghai Biotechnology, if not explicitly stated
EXAMPLE 1 preparation of DrRuvC protein
1. Construction of DrRuvC prokaryotic expression vector:
the gene encoding DrRuvC was amplified directly from the genome of P.radiodurans using the primers DrRuvC-FN (5'-TACTTCCAAGGTCATATGAGGGTTCTGGGGATTGACCC-3', SEQ NO. 1) and DrRuvC-RB (5 'GAGCTCGAATTCGGATCTCGCGCCGCAGCGG-3', SEQ NO. 2), after confirming the correct size of the amplified fragment by agarose gel detection (FIG. 1), the PCR fragment was recovered using a gel recovery kit (Shanghai JieRuy), the fragment was ligated to a linearized pET28T expression vector which had been treated with NdeI and BamHI restriction enzymes and recovered, the ligation product was transformed into DH 5. Alpha. Clone competent, single colony sequencing was taken on LB plates containing Kana resistance (final concentration 50 mg/L), and after correct sequencing, a recombinant expression vector T28T-drruvC (FIG. 2) was proposed, which was able to express 6 DrvC tags at the N-terminal of the heterologous E.coli strain.
The linearized pET28T plasmid is a plasmid modified based on a commercialized pET28a plasmid, the main modification is that the sequence 'GGCCTGGTGCCGCGCGGCAGC' behind the His tag of the original pET28a plasmid is replaced by 'GAGAACCTGTACTTCCAAGGT', the new sequence just codes a TEV enzyme cutting site 'ENLYFQG', the modified expression plasmid can be fused and expressed at the N end of a target protein to form a section of short peptide 'MGSSHHHHHHSSENLYFQGH', the short peptide is favorable for carrying out affinity chromatography purification on the target protein by utilizing a nickel column at the later stage, the size of the short peptide generally does not influence the corresponding enzyme activity, in addition, the short peptide can be cut off by utilizing TEV enzyme when necessary, only two 'GH' amino acids are reserved at the N end of the target protein, and redundant amino acids irrelevant to the activity of the target protein are reduced to the greatest extent.
The nucleotide sequence of the gene encoding DrRuvC is specifically as follows:
atgagggttctggggattgaccccggtctggcgaacctgggcctgggactggtcgaaggggatgtccggcgggccaagcacctgtaccacgtctgcctgaccaccgaaagcgcgtggctgatgccccggcggctgcaatacctgcacgaggaactgacccggctgctcaccgagtaccggcccgacgcggtggcgatcgaggaccagattctgcgccgacaggctgacgtggcgttcaaagtggggcaggcgttcggggtggtgcagctcgcctgtgcgcaggccggggtgccgattcacgcctacggccccatgcaggtcaagaagtcgctggtgggcacgggccgcgccgacaaggagcaggtcatctacatggtcaaggcgagcctgggtattcgcgagctgttcaacaaccacgccgccgacgcgctggctctggcgctgacccacctcgcgcacgcgcccatgcaggagcgcagcgagcggctggcggcggcgggcagggctgcgcgcacaggagacgccccgctgcggcgctga, SEQ NO.3.
2. Heterologous expression of DrRuvC protein: the expression vector pET28T-drruvC was transformed into E.coli expression strain Rosetta (DE 3) and plated on LB plates containing Kana resistance (final concentration 50 mg/L) and chloramphenicol (final concentration 30 mg/L). Single colony is picked up and inoculated into 5ml of LB liquid medium, the culture is cultured overnight at 37 ℃, the culture is transferred into 1LLB liquid medium for expansion culture, when the OD of the bacterial liquid reaches 0.8, 0.8mM isopropyl-beta-D-thiogalactoside is added into the culture medium, meanwhile, the bacterial liquid is transferred to 18 ℃ for overnight culture (the target protein is expressed in a large amount at the step), then bacterial is collected, and the supernatant is discarded.
3. Purification of DrRuvC protein: the cells obtained in step 2 were suspended in a lysate (20 mM Tris [ pH8.0], 1M NaCl, 0.5mM Tris [ 2-carboxyyl ] phosphine [ TCEP ] and 5mM imidazole), lysed by a pressure breaker, and then centrifuged at 20000g at 4℃for 60 minutes to collect the supernatant. The supernatant was filtered with a 0.22 μm filter membrane, and then, a nickel column (nickel column A equilibrium, 6% nickel column B wash out the impurity protein, 100% nickel column B wash out), a desalting column (desalting A equilibrium and elution), a heparin sulfate column (heparin sulfate A equilibrium, 0-50% heparin sulfate B gradient elution) and a molecular sieve column (molecular sieve A equilibrium and elution) were sequentially used to obtain a very pure target protein. As described above, 1mg of DrRuvC protein with a purity of 99% or more can be finally obtained per liter of the bacterial culture. The purity of the final DrRuvC protein was determined by 15% SDS-PAGE (FIG. 3B). The purified DrRuvC molecular sieve (Superdex 75) pattern showed a peak position of 10ml, corresponding molecular weight of about 40-45kDa, and a molecular weight of about 20kDa for the DrRuvC monomer, demonstrating that DrRuvC exists in solution as homodimers (FIG. 3A). The buffer formulation used for the purification process was as follows:
(1) Nickel column a solution: 20mM Tris (pH 8.0), 1M NaCl, 0.5mM TCEP and 5mM imidazole; nickel column B solution: 20mM Tris (pH 8.0), 1M NaCl, 0.5mM TCEP and 500mM imidazole.
(2) Desalting solution A: 20mM Tris (pH 8.0), 100mM NaCl, 0.5mM TCEP.
(3) Heparin sulfate A solution: 20mM Tris (pH 8.0), 100mM NaCl, 0.5mM TCEP; heparin sulfate solution B: 20mM Tris (pH 8.0), 2M NaCl, 0.5mM TCEP.
(4) Molecular sieve A solution: 20mM Tris (pH 8.0), 100mM NaCl, 0.5mM TCEP.
The DrRuvC protein expressed in the engineering bacteria has the following amino acid sequence:
MGSSHHHHHHSSENLYFQGHMRVLGIDPGLANLGLGLVEGDVRRAKHLYHVCLTTESAWLMPRRLQYLHEELTRLLTEYRPDAVAIEDQILRRQADVAFKVGQAFGVVQLACAQAGVPIHAYGPMQVKKSLVGTGRADKEQVIYMVKASLGIRELFNNHAADALALALTHLAHAPMQERSERLAAAGRAARTGDAPLRR, SEQ NO.4.
Example 2 detection of DrRuvC Activity and screening of optimal substrates
1. The following sequence anneals were used to form an artificially synthesized holliday linker substrate containing a 66nt homologous sequence region for detection of DrRuvC activity (see fig. 4). Wherein FAM-J98-1, J98-2, J98-3 and J98-4 can anneal to form a holliday linker substrate HJ98a, and J98-1, FAM-J98-2, J98-3 and J98-4 can anneal to form a holliday linker substrate HJ98b, the portion of the sequence that is depicted as a horizontal line being a region of homologous sequence of the holliday linker.
The annealing conditions were: the sequences were mixed in equal proportions, heated to 95℃in 20mM Tris (pH 8.0), 50mM NaCl and 0.5mM TCEP buffer, and cooled slowly to room temperature over 2 hours.
The reaction process of the dissociation of the holliday linker is as follows: 10 μl of the reaction system contains 1 μM DrRuvC protein (or recombinant EcRuvC protein sold by abcam corporation as control), 500nM of holliday linker substrate HJ98a or HJ98b, 100mM NaCl, 10mM MgCl 2 Or MnCl 2 20mM Tris (pH 8.0), 0.5mM TCEP, 5% glycerol. The reaction was allowed to stand at 37℃for 30 minutes, then was quenched by the addition of an equal volume of stop solution A (containing 20mM EDTA and 98% formamide), heated at 100℃for 20 minutes, and immediately transferred to ice quenching.
Because the 5' end of the corresponding sequence in the substrate is provided with a 6-FAM fluorescent group, the enzyme digestion product of the sequence can be separated by 15% TBE urea gum (200V constant pressure for 40 minutes) and detected by a fluorescent gum-sweeping instrument with corresponding wavelength. The leftmost lane of the gel is a single-stranded DNAmarker. In addition, ec ruvc is a recombinant ec ruvc protein sold by abcam corporation (cat No. P0a 814) as a control.
The final reaction results showed that DrRuvC was different from EcRuvC in the cleavage sites for HJ98a and HJ98b, with DrRuvC cleavage sites being mainly near sequences containing "TC" and EcRuvC cleavage sites being mainly near sequences containing "TT" (see fig. 4). It can be seen that DrRuvC is a novel holliday linker dissociating enzyme with a different activity than ectruvc.
2. Based on the results of step 1, a shorter holliday linker substrate HJ31 was designed to more precisely locate the cleavage site of DrRuvC. The holliday linker substrate HJ31 (see fig. 5) was formed by co-annealing FAM-J31-1, J31-2, J31-3 and J31-4 in the same proportions. The sequence involved is as follows:
the annealing conditions were: the sequences were mixed in equal proportions, heated to 95℃in 20mM Tris (pH 8.0), 50mM NaCl and 0.5mM TCEP buffer, and cooled slowly to room temperature over 2 hours.
The reaction process of the dissociation of the holliday linker is as follows: 10 μl of the reaction system contains 1 μM DrRuvC protein (or recombinant EcRuvC protein sold by abcam as control), 500nM of holliday linker substrate HJ31, 100mM NaCl, 10mM MnCl 2 20mM Tris (pH 8.0), 0.5mM TCEP, 5% glycerol. The reaction was allowed to stand at 37℃for 30 minutes, then was quenched by the addition of an equal volume of a stop solution A (containing 20mM EDTA and 98% formamide), heated at 100℃for 20 minutes, immediately transferred to ice for quenching, and then the product was isolated by means of 15% TBE urea gum (200V constant pressure for 50 minutes) and detected by means of a fluorescent gum-scanner of the corresponding wavelength. The leftmost lane of the gel is a single-stranded DNA marker. In addition, ec ruvc served as a control.
The final reaction results showed that DrRuvC was different from EcRuvC on the cleavage site of HJ31, drRuvC was mainly breaking the phosphodiester bond after cytosine in "TC", and EcRuvC was mainly breaking the phosphodiester bond after thymine in "TT" (see fig. 5). Further described is that DrRuvC is a novel holliday linker dissociating enzyme with a different activity than ectruvc.
3. Based on the results of steps 1 and 2, different bases were designed around "TC" to more precisely determine the DrRuvC-favored Holidar linker substrate sequence. In J24-N 1 N 2 N 3 N 4 -1、24-D 1 D 2 D 3 D 4 -2、24-N 1 N 2 N 3 N 4 -3 and 24-D 1 D 2 D 3 D 4 -4 (wherein N 1 N 2 N 3 N 4 And D 1 D 2 D 3 D 4 Is a variable base) and the like, can form a holliday linker substrate HJ24-N 1 N 2 N 3 N 4 (see FIG. 6). The sequence involved is as follows:
the annealing conditions were: the sequences were mixed in equal proportions, heated to 95℃in 20mM Tris (pH 8.0), 50mM NaCl and 0.5mM TCEP buffer, and cooled slowly to room temperature over 2 hours.
The reaction process of the dissociation of the holliday linker is as follows: 10. Mu.l of the reaction system contained 5. Mu.M of DrRuvC protein (or recombinant EcRuvC protein sold by abcam Co., ltd.) as a control, 2.5. Mu.M of the holliday linker substrate HJ24-N 1 N 2 N 3 N 4 、100mM NaCl、10mM MnCl 2 20mM Tris (pH 8.0), 0.5mM TCEP, 5% glycerol. After reaction at 37℃for 30 minutes, the reaction was stopped by adding an equal volume of stop solution B (containing 20mM EDTA and 10mg/mL proteinase K), and after stopping the reaction at 37℃for 20 minutes, the product was isolated with 10% TBE-active gel (100V constant pressure for 50 minutes) and the gel was stained with Stains-all dye (Bio-technology) and photographed.
The final reaction results show that DrRuvC prefers to dissociate holliday linkers containing 5'- (G/C) TC (G/C) -3' sequences at the junction (see fig. 6).
Example 3: drRuvC enzyme activity condition optimization
1. Screening of DrRuvC optimum catalytic metal ions and concentration. The optimal catalytic metal ions and concentrations of DrRuvC were screened using the holliday linker HJ31 of example 2 as a substrate.
Wherein the screening process of the optimal metal ions for the enzyme activity reaction comprises the following steps: mu.l of the reaction system contained 1. Mu.M of DrRuvC protein, 500nM of the Holiday linker substrate HJ31, 100mM NaCl, 10mM metal ion (MgCl) 2 、MnCl 2 、CaCl 2 、ZnSO 4 、NiCl 2 、CoCl 2 And CuCl 2 ) 20mM Tris (pH 8.0), 0.5mM TCEP, 5% glycerol. The reaction was allowed to stand at 37℃for 30 minutes, then was quenched by the addition of an equal volume of a stop solution A (containing 20mM EDTA and 98% formamide), heated at 100℃for 20 minutes, immediately transferred to ice for quenching, and then the product was isolated by means of 15% TBE urea gum (200V constant pressure for 40 minutes) and detected by means of a fluorescent gum-scanner of the corresponding wavelength. The scan results were subjected to a banding analysis using ImageJ software (National Institutes of Health, USA) to determine the ratio of product and substrate bands after catalytic dissociation of each metal ion, respectively, and then a bar graph of dissociation efficiency of each metal ion under the reaction conditions was drawn using GraphPad Prism9 (San Diego, USA). Finally, mn ions and Mg ions are found to have better catalytic effect, and other metals have little activity (see FIG. 7A).
Wherein the metal ion concentration optimization process is as follows: 10 μl of the reaction system contains 1 μM DrRuvC protein, 500nM of the Holiday linker substrate HJ31, 100mM NaCl, different concentrations of MgCl 2 Or MnCl 2 (0.31, 0.625, 1.25, 2.5, 5, 10, 20 mM), 20mM Tris (pH 8.0), 0.5mM TCEP, 5% glycerol. The reaction was allowed to stand at 37℃for 30 minutes, then was quenched by the addition of an equal volume of a stop solution A (containing 20mM EDTA and 98% formamide), heated at 100℃for 20 minutes, immediately transferred to ice for quenching, and then the product was isolated by means of 15% TBE urea gum (200V constant pressure for 40 minutes) and detected by means of a fluorescent gum-scanner of the corresponding wavelength. The scan results were subjected to banding analysis using ImageJ software to determine the proportion of product and substrate bands for each lane, respectively, followed by plotting lines of dissociation efficiency at different metal ion concentrations using GraphPad Prism 9. It was finally found that DrRuvC has the strongest enzyme activity at Mn ion concentrations of 2.5-10mM and the strongest enzyme activity at Mg ion concentrations of 20mM. However, in general, the catalytic efficiency of Mn ions isStronger than Mg ion, is the best catalytic metal ion for DrRuvC (see fig. 7B).
2. Screening of optimal pH for DrRuvC reaction conditions. The process is as follows: mu.l of the reaction system contains 1. Mu.M of DrRuvC protein, 500nM of the Holiday linker substrate HJ31, 100mM NaCl, 10mM MnCl 2 50mM buffers of different pH (wherein buffers of pH 5.6, 6.0, 6.4, 6.8, 7.2 are prepared from Bis-Tris and hydrochloric acid, and buffers of pH7.6, 8.0, 8.4, 8.8, 9.2 are prepared from Tris and hydrochloric acid), 0.5mM TCEP, 5% glycerol. The reaction was allowed to stand at 37℃for 30 minutes, then was quenched by the addition of an equal volume of a stop solution A (containing 20mM EDTA and 98% formamide), heated at 100℃for 20 minutes, immediately transferred to ice for quenching, and then the product was isolated by means of 15% TBE urea gum (200V constant pressure for 40 minutes) and detected by means of a fluorescent gum-scanner of the corresponding wavelength. The scan results were subjected to banding analysis using ImageJ software to determine the proportion of product and substrate bands for each lane, respectively, followed by plotting lines of dissociation efficiency at different metal ion concentrations using GraphPadPrism 9. Finally, drRuvC was found to have a strong activity in the pH range of 7.6-8.4, with the strongest enzyme activity at pH8.0 (see FIG. 8).
3. Screening of optimal NaCl concentration for DrRuvC reaction conditions. The process is as follows: 10 μl of the reaction system contains 1 μM of DrRuvC protein, 500nM of the hollydi linker substrate HJ31, 10mM MnCl 2 20mM Tris (pH 8.0), naCl at different concentrations (final concentrations 50, 100, 150, 200, 250, 300, 350, 400, 450, 500mM respectively), 0.5mM TCEP, 5% glycerol. The reaction was allowed to stand at 37℃for 30 minutes, then was quenched by the addition of an equal volume of a stop solution A (containing 20mM EDTA and 98% formamide), heated at 100℃for 20 minutes, immediately transferred to ice for quenching, and then the product was isolated by means of 15% TBE urea gum (200V constant pressure for 40 minutes) and detected by means of a fluorescent gum-scanner of the corresponding wavelength. The scan results were subjected to banding analysis using ImageJ software to determine the proportion of product and substrate bands for each lane, respectively, followed by plotting lines of dissociation efficiency at different metal ion concentrations using GraphPad Prism 9. Finally, drRuvC was found to have the strongest activity at NaCl final concentrations ranging from 50 to 150mM (see FIG. 9).
4. Optimum DrRuvC reaction conditionsAnd (5) screening reaction temperature. 10 μl of the reaction system contains 1 μM of DrRuvC protein, 500nM of the hollydi linker substrate HJ31, 10mM MnCl 2 20mM Tris (pH 8.0), 100mM NaCl, 0.5mM TCEP, 5% glycerol. The reaction was stopped by allowing to stand at different temperatures (15 ℃, 20 ℃, 25 ℃, 30 ℃, 35 ℃, 40 ℃, 45 ℃,50 ℃, 55 ℃, 60 ℃) for 30 minutes, then adding an equal volume of stop solution A (containing 20mM EDTA and 98% formamide), heating at 100 ℃ for 20 minutes, immediately transferring to ice for quenching, then separating the product by using 15% TBE urea gum (200V constant pressure for 40 minutes), and detecting by using a fluorescent gum scanner of corresponding wavelength. The scan results were subjected to banding analysis using ImageJ software to determine the proportion of product and substrate bands for each lane, respectively, followed by plotting lines of dissociation efficiency at different metal ion concentrations using GraphPad Prism 9. Finally, drRuvC was found to be the most active at a reaction temperature in the range of 40-45℃ (see FIG. 10).
Sequence listing
<110> Hangzhou university of education
<120> a holliday connector dissociating enzyme DrRuvC, and encoding gene and application thereof
<160> 78
<170> SIPOSequenceListing 1.0
<210> 1
<211> 38
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
tacttccaag gtcatatgag ggttctgggg attgaccc 38
<210> 2
<211> 34
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 2
gagctcgaat tcggatcctc agcgccgcag cggg 34
<210> 3
<211> 540
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
atgagggttc tggggattga ccccggtctg gcgaacctgg gcctgggact ggtcgaaggg 60
gatgtccggc gggccaagca cctgtaccac gtctgcctga ccaccgaaag cgcgtggctg 120
atgccccggc ggctgcaata cctgcacgag gaactgaccc ggctgctcac cgagtaccgg 180
cccgacgcgg tggcgatcga ggaccagatt ctgcgccgac aggctgacgt ggcgttcaaa 240
gtggggcagg cgttcggggt ggtgcagctc gcctgtgcgc aggccggggt gccgattcac 300
gcctacggcc ccatgcaggt caagaagtcg ctggtgggca cgggccgcgc cgacaaggag 360
caggtcatct acatggtcaa ggcgagcctg ggtattcgcg agctgttcaa caaccacgcc 420
gccgacgcgc tggctctggc gctgacccac ctcgcgcacg cgcccatgca ggagcgcagc 480
gagcggctgg cggcggcggg cagggctgcg cgcacaggag acgccccgct gcggcgctga 540
<210> 4
<211> 199
<212> PRT
<213> Artificial sequence (Artificial Sequence)
<400> 4
Met Gly Ser Ser His His His His His His Ser Ser Glu Asn Leu Tyr
1 5 10 15
Phe Gln Gly His Met Arg Val Leu Gly Ile Asp Pro Gly Leu Ala Asn
20 25 30
Leu Gly Leu Gly Leu Val Glu Gly Asp Val Arg Arg Ala Lys His Leu
35 40 45
Tyr His Val Cys Leu Thr Thr Glu Ser Ala Trp Leu Met Pro Arg Arg
50 55 60
Leu Gln Tyr Leu His Glu Glu Leu Thr Arg Leu Leu Thr Glu Tyr Arg
65 70 75 80
Pro Asp Ala Val Ala Ile Glu Asp Gln Ile Leu Arg Arg Gln Ala Asp
85 90 95
Val Ala Phe Lys Val Gly Gln Ala Phe Gly Val Val Gln Leu Ala Cys
100 105 110
Ala Gln Ala Gly Val Pro Ile His Ala Tyr Gly Pro Met Gln Val Lys
115 120 125
Lys Ser Leu Val Gly Thr Gly Arg Ala Asp Lys Glu Gln Val Ile Tyr
130 135 140
Met Val Lys Ala Ser Leu Gly Ile Arg Glu Leu Phe Asn Asn His Ala
145 150 155 160
Ala Asp Ala Leu Ala Leu Ala Leu Thr His Leu Ala His Ala Pro Met
165 170 175
Gln Glu Arg Ser Glu Arg Leu Ala Ala Ala Gly Arg Ala Ala Arg Thr
180 185 190
Gly Asp Ala Pro Leu Arg Arg
195
<210> 5
<211> 98
<212> DNA
<213> FAM-J98-1
<400> 5
ttctaagacc ctgaaccact cgggaaataa caagatttca tctatgacca gtacgagctt 60
aggttgtcct ggcccgcgtg caaaggatga cagaagca 98
<210> 6
<211> 98
<212> DNA
<213> J98-1
<400> 6
ttctaagacc ctgaaccact cgggaaataa caagatttca tctatgacca gtacgagctt 60
aggttgtcct ggcccgcgtg caaaggatga cagaagca 98
<210> 7
<211> 98
<212> DNA
<213> FAM-J98-2
<400> 7
tgcttctgtc atcctttgca cgcgggccag gacaacctaa gctcgtactg gtcatagatg 60
aaatcttgtt atttcccgag tgtcaatcca tacttcgt 98
<210> 8
<211> 98
<212> DNA
<213> J98-2
<400> 8
tgcttctgtc atcctttgca cgcgggccag gacaacctaa gctcgtactg gtcatagatg 60
aaatcttgtt atttcccgag tgtcaatcca tacttcgt 98
<210> 9
<211> 98
<212> DNA
<213> J98-3
<400> 9
acgaagtatg gattgacact cgggaaataa caagatttca tctatgacca gtacgagctt 60
aggttgtcct ggcccgcgtg cagattctca agatgact 98
<210> 10
<211> 98
<212> DNA
<213> J98-4
<400> 10
agtcatcttg agaatctgca cgcgggccag gacaacctaa gctcgtactg gtcatagatg 60
aaatcttgtt atttcccgag tggttcaggg tcttagaa 98
<210> 11
<211> 31
<212> DNA
<213> FAM-J31-1
<400> 11
gctagccaca gccattcgga cgattgcggg a 31
<210> 12
<211> 31
<212> DNA
<213> J31-2
<400> 12
tcccgcaatc gtccgaaacc gagcacgatc t 31
<210> 13
<211> 31
<212> DNA
<213> J31-3
<400> 13
agatcgtgct cggtttccca ccagatgcca t 31
<210> 14
<211> 31
<212> DNA
<213> J31-4
<400> 14
atggcatctg gtccgaatgg ctgtggctag c 31
<210> 15
<211> 24
<212> DNA
<213> J24-TTCG-1
<400> 15
gccacagcca ttcgcccatt gcgt 24
<210> 16
<211> 24
<212> DNA
<213> J24-TTCG-2
<400> 16
acgcaatggg cgaaaccgag cacg 24
<210> 17
<211> 24
<212> DNA
<213> J24-TTCG-3
<400> 17
cgtgctcggt ttcgtgcaga tgcc 24
<210> 18
<211> 24
<212> DNA
<213> J24-TTCG-4
<400> 18
ggcatctgca cgaatggctg tggc 24
<210> 19
<211> 24
<212> DNA
<213> J24-ATCG-1
<400> 19
gccacagcca atcgcccatt gcgt 24
<210> 20
<211> 24
<212> DNA
<213> J24-ATCG-2
<400> 20
acgcaatggg cgataccgag cacg 24
<210> 21
<211> 24
<212> DNA
<213> J24-ATCG-3
<400> 21
cgtgctcggt atcgtgcaga tgcc 24
<210> 22
<211> 24
<212> DNA
<213> J24-ATCG-4
<400> 22
ggcatctgca cgattggctg tggc 24
<210> 23
<211> 24
<212> DNA
<213> J24-CTCG-1
<400> 23
gccacagcca ctcgcccatt gcgt 24
<210> 24
<211> 24
<212> DNA
<213> J24-CTCG-2
<400> 24
acgcaatggg cgagaccgag cacg 24
<210> 25
<211> 24
<212> DNA
<213> J24-CTCG-3
<400> 25
cgtgctcggt ctcgtgcaga tgcc 24
<210> 26
<211> 24
<212> DNA
<213> J24-CTCG-4
<400> 26
ggcatctgca cgagtggctg tggc 24
<210> 27
<211> 24
<212> DNA
<213> J24-GTCG-1
<400> 27
gccacagcca gtcgcccatt gcgt 24
<210> 28
<211> 24
<212> DNA
<213> J24-GTCG-2
<400> 28
acgcaatggg cgacaccgag cacg 24
<210> 29
<211> 24
<212> DNA
<213> J24-GTCG-3
<400> 29
cgtgctcggt gtcgtgcaga tgcc 24
<210> 30
<211> 24
<212> DNA
<213> J24-GTCG-4
<400> 30
ggcatctgca cgactggctg tggc 24
<210> 31
<211> 24
<212> DNA
<213> J24-TTCC-1
<400> 31
gccacagcca ttcccccatt gcgt 24
<210> 32
<211> 24
<212> DNA
<213> J24-TTCC-2
<400> 32
acgcaatggg ggaaaccgag cacg 24
<210> 33
<211> 24
<212> DNA
<213> J24-TTCC-3
<400> 33
cgtgctcggt ttcctgcaga tgcc 24
<210> 34
<211> 24
<212> DNA
<213> J24-TTCC-4
<400> 34
ggcatctgca ggaatggctg tggc 24
<210> 35
<211> 24
<212> DNA
<213> J24-ATCC-1
<400> 35
gccacagcca atcccccatt gcgt 24
<210> 36
<211> 24
<212> DNA
<213> J24-ATCC-2
<400> 36
acgcaatggg ggataccgag cacg 24
<210> 37
<211> 24
<212> DNA
<213> J24-ATCC-3
<400> 37
cgtgctcggt atcctgcaga tgcc 24
<210> 38
<211> 24
<212> DNA
<213> J24-ATCC-4
<400> 38
ggcatctgca ggattggctg tggc 24
<210> 39
<211> 24
<212> DNA
<213> J24-CTCC-1
<400> 39
gccacagcca ctcccccatt gcgt 24
<210> 40
<211> 24
<212> DNA
<213> J24-CTCC-2
<400> 40
acgcaatggg ggagaccgag cacg 24
<210> 41
<211> 24
<212> DNA
<213> J24-CTCC-3
<400> 41
cgtgctcggt ctcctgcaga tgcc 24
<210> 42
<211> 24
<212> DNA
<213> J24-CTCC-4
<400> 42
ggcatctgca ggagtggctg tggc 24
<210> 43
<211> 24
<212> DNA
<213> J24-GTCC-1
<400> 43
gccacagcca gtcccccatt gcgt 24
<210> 44
<211> 24
<212> DNA
<213> J24-GTCC-2
<400> 44
acgcaatggg ggacaccgag cacg 24
<210> 45
<211> 24
<212> DNA
<213> J24-GTCC-3
<400> 45
cgtgctcggt gtcctgcaga tgcc 24
<210> 46
<211> 24
<212> DNA
<213> J24-GTCC-4
<400> 46
ggcatctgca ggactggctg tggc 24
<210> 47
<211> 24
<212> DNA
<213> J24-TTCA-1
<400> 47
gccacagcca ttcacccatt gcgt 24
<210> 48
<211> 24
<212> DNA
<213> J24-TTCA-2
<400> 48
acgcaatggg tgaaaccgag cacg 24
<210> 49
<211> 24
<212> DNA
<213> J24-TTCA-3
<400> 49
cgtgctcggt ttcatgcaga tgcc 24
<210> 50
<211> 24
<212> DNA
<213> J24-TTCA-4
<400> 50
ggcatctgca tgaatggctg tggc 24
<210> 51
<211> 24
<212> DNA
<213> J24-ATCA-1
<400> 51
gccacagcca atcacccatt gcgt 24
<210> 52
<211> 24
<212> DNA
<213> J24-ATCA-2
<400> 52
acgcaatggg tgataccgag cacg 24
<210> 53
<211> 24
<212> DNA
<213> J24-ATCA-3
<400> 53
cgtgctcggt atcatgcaga tgcc 24
<210> 54
<211> 24
<212> DNA
<213> J24-ATCA-4
<400> 54
ggcatctgca tgattggctg tggc 24
<210> 55
<211> 24
<212> DNA
<213> J24-CTCA-1
<400> 55
gccacagcca ctcacccatt gcgt 24
<210> 56
<211> 24
<212> DNA
<213> J24-CTCA-2
<400> 56
acgcaatggg tgagaccgag cacg 24
<210> 57
<211> 24
<212> DNA
<213> J24-CTCA-3
<400> 57
cgtgctcggt ctcatgcaga tgcc 24
<210> 58
<211> 24
<212> DNA
<213> J24-CTCA-4
<400> 58
ggcatctgca tgagtggctg tggc 24
<210> 59
<211> 24
<212> DNA
<213> J24-GTCA-1
<400> 59
gccacagcca gtcacccatt gcgt 24
<210> 60
<211> 24
<212> DNA
<213> J24-GTCA-2
<400> 60
acgcaatggg tgacaccgag cacg 24
<210> 61
<211> 24
<212> DNA
<213> J24-GTCA-3
<400> 61
cgtgctcggt gtcatgcaga tgcc 24
<210> 62
<211> 24
<212> DNA
<213> J24-GTCA-4
<400> 62
ggcatctgca tgactggctg tggc 24
<210> 63
<211> 24
<212> DNA
<213> J24-TTCT-1
<400> 63
gccacagcca ttctcccatt gcgt 24
<210> 64
<211> 24
<212> DNA
<213> J24-TTCT-2
<400> 64
acgcaatggg agaaaccgag cacg 24
<210> 65
<211> 24
<212> DNA
<213> J24-TTCT-3
<400> 65
cgtgctcggt ttcttgcaga tgcc 24
<210> 66
<211> 24
<212> DNA
<213> J24-TTCT-4
<400> 66
ggcatctgca agaatggctg tggc 24
<210> 67
<211> 24
<212> DNA
<213> J24-ATCT-1
<400> 67
gccacagcca atctcccatt gcgt 24
<210> 68
<211> 24
<212> DNA
<213> J24-ATCT-2
<400> 68
acgcaatggg agataccgag cacg 24
<210> 69
<211> 24
<212> DNA
<213> J24-ATCT-3
<400> 69
cgtgctcggt atcttgcaga tgcc 24
<210> 70
<211> 24
<212> DNA
<213> J24-ATCT-4
<400> 70
ggcatctgca agattggctg tggc 24
<210> 71
<211> 24
<212> DNA
<213> J24-CTCT-1
<400> 71
gccacagcca ctctcccatt gcgt 24
<210> 72
<211> 24
<212> DNA
<213> J24-CTCT-2
<400> 72
acgcaatggg agagaccgag cacg 24
<210> 73
<211> 24
<212> DNA
<213> J24-CTCT-3
<400> 73
cgtgctcggt ctcttgcaga tgcc 24
<210> 74
<211> 24
<212> DNA
<213> J24-CTCT-4
<400> 74
ggcatctgca agagtggctg tggc 24
<210> 75
<211> 24
<212> DNA
<213> J24-GTCT-1
<400> 75
gccacagcca gtctcccatt gcgt 24
<210> 76
<211> 24
<212> DNA
<213> J24-GTCT-2
<400> 76
acgcaatggg agacaccgag cacg 24
<210> 77
<211> 24
<212> DNA
<213> J24-GTCT-3
<400> 77
cgtgctcggt gtcttgcaga tgcc 24
<210> 78
<211> 24
<212> DNA
<213> J24-GTCT-4
<400> 78
ggcatctgca agactggctg tggc 24
Claims (2)
1. A method for dissociating a Holiday connector is characterized in that 10 mul of a reaction system is placed at 40-45 ℃ for 30 minutes, then an equal volume of stop solution A is added for stopping the reaction, heating is carried out at 100 ℃ for 20 minutes, the mixture is transferred to ice for quenching, and then TBE urea gum is utilized for separating products; the stop solution A is 20mM EDTA and 98% formamide;
the 10 mu l reaction system contains 1 mu M of enzyme DrRuvC, holliday connector substrate containing 5'- (G/C) TC (G/C) -3' sequence at 500nM junction, 50-150mM NaCl, a certain concentration of metal ions, 20mM Tris with pH of 7.6-8.4, 0.5mM TCEP and 5% glycerol; the amino acid sequence of the enzyme DrRuvC is shown as SEQ NO.4;
the metal ion is Mn or Mg; when the metal ion is Mn, the concentration of Mn ions in the reaction system is 2.5-10 mM; when the metal ion is Mg, the concentration of the Mg ion in the reaction system is 20mM.
2. A method for dissociating a Holiday connector is characterized in that 10 mul of a reaction system is placed at 40-45 ℃ to react for 30 minutes, then an equal volume of stop solution B is added to stop the reaction, and after the reaction is stopped at 37 ℃ for 20 minutes, TBE active glue is utilized to separate products; the stop solution B is 20mM EDTA and 10mg/mL proteinase K;
the 10 mu l reaction system contains 1 mu M of enzyme DrRuvC, holliday connector substrate containing 5'- (G/C) TC (G/C) -3' sequence at 500nM junction, 50-150mM NaCl, a certain concentration of metal ions, 20mM Tris with pH of 7.6-8.4, 0.5mM TCEP and 5% glycerol; the amino acid sequence of the enzyme DrRuvC is shown as SEQ NO.4;
the metal ion is Mn or Mg; when the metal ion is Mn, the concentration of Mn ions in the reaction system is 2.5-10 mM; when the metal ion is Mg, the concentration of the Mg ion in the reaction system is 20mM.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210399536.XA CN114807086B (en) | 2022-04-15 | 2022-04-15 | Holliday connector dissociating enzyme DrRuvC and encoding gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210399536.XA CN114807086B (en) | 2022-04-15 | 2022-04-15 | Holliday connector dissociating enzyme DrRuvC and encoding gene and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114807086A CN114807086A (en) | 2022-07-29 |
CN114807086B true CN114807086B (en) | 2024-02-20 |
Family
ID=82536474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210399536.XA Active CN114807086B (en) | 2022-04-15 | 2022-04-15 | Holliday connector dissociating enzyme DrRuvC and encoding gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114807086B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1906292A (en) * | 2003-11-21 | 2007-01-31 | 新英格兰生物实验室公司 | Modificatory DNA incision enzyme and its application method |
CN111518782A (en) * | 2020-03-24 | 2020-08-11 | 广东广业清怡食品科技有限公司 | Glycosyltransferase UGTZJ1 mutant and application thereof |
CN112585272A (en) * | 2018-06-01 | 2021-03-30 | 阿尔根技术有限公司 | Gene targeting |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009137778A2 (en) * | 2008-05-08 | 2009-11-12 | Northwestern University | Methods and compositions for genetically engineering clostridia species |
EP3575396A1 (en) * | 2018-06-01 | 2019-12-04 | Algentech SAS | Gene targeting |
-
2022
- 2022-04-15 CN CN202210399536.XA patent/CN114807086B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1906292A (en) * | 2003-11-21 | 2007-01-31 | 新英格兰生物实验室公司 | Modificatory DNA incision enzyme and its application method |
CN112585272A (en) * | 2018-06-01 | 2021-03-30 | 阿尔根技术有限公司 | Gene targeting |
CN111518782A (en) * | 2020-03-24 | 2020-08-11 | 广东广业清怡食品科技有限公司 | Glycosyltransferase UGTZJ1 mutant and application thereof |
Non-Patent Citations (6)
Title |
---|
Biochemical and structural characterization of the Holliday junction resolvase RuvC from Pseudomonas aeruginosa;Yi Hu等;Biochemical and Biophysical Research Communications;265-271 * |
Biochemical characterization of a unique DNA polymerase A from the extreme radioresistant organism Deinococcus radiodurans;Xingru Zhou等;Biochimie;22-32 * |
Deinococcus radiodurans strain BND-54 chromosome 1, complete sequence,GenBank: CP050120.1;Jung,J.-H.等;Genbank;FEATURES和ORIGIN * |
Jung,J.-H.等.Deinococcus radiodurans strain BND-54 chromosome 1, complete sequence,GenBank: CP050120.1.Genbank.2020,FEATURES和ORIGIN. * |
Structural asymmetry in the Thermus thermophilus RuvC dimer suggests a basis for sequential strand cleavages during Holliday junction resolution;Luan Chen等;Nucleic Acids Research;第41卷(第1期);摘要,第649页材料和方法部分,第650页图1 * |
耐辐射奇球菌同源重组修复机制研究新进展;华孝挺等;核农学报;第24卷(第6期);1192-1197 * |
Also Published As
Publication number | Publication date |
---|---|
CN114807086A (en) | 2022-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5643758A (en) | Production and purification of a protein fused to a binding protein | |
AU626521B2 (en) | Production and purification of a protein fused to a binding protein | |
US4349629A (en) | Plasmid vectors, production anduse thereof | |
JPH074255B2 (en) | DNA expression vector for expressing hybrid polypeptide in transformed host cell | |
CN111278852A (en) | Production method of recombinant Erwinia asparaginase | |
CN113136374A (en) | Preparation and application of recombinant mutant Tn5 transposase | |
CN112063643A (en) | Expression vector and method for detecting interaction of membrane proteins in bacteria | |
EP0614982B1 (en) | Recombinant vector for the exocellular preparation of single chain antibodies expressed in bacillus subtilis | |
AU8640798A (en) | Recombinant expression of insulin c-peptide | |
CN114807086B (en) | Holliday connector dissociating enzyme DrRuvC and encoding gene and application thereof | |
EP0587541B1 (en) | Process to purify the big-endothelin protein | |
Zhang et al. | Escherichia coli RNase D: sequencing of the rnd structural gene and purification of the overexpressed protein | |
CN114645033B (en) | Nucleoside triphosphate hydrolase and purification method and application thereof | |
EP1981978B1 (en) | Affinity polypeptide for purification of recombinant proteins | |
CN112391367A (en) | Preparation method of Cas9 protein for gene editing of human primary cells | |
US7211647B2 (en) | DNA synthetase | |
CN112813088B (en) | Preparation method of recombinant DpnI restriction enzyme | |
CN114480347B (en) | Method for purifying Cas12a protein | |
CN111088243B (en) | Aminopeptidase LapA site-directed mutant protein and application thereof | |
CN116355932B (en) | Recombinant vector and method for preparing mu-conotoxin | |
CN109055332B (en) | Mutant exonuclease, coding gene and application thereof | |
US6277614B1 (en) | Deoxyribonuclease | |
CN116334051A (en) | Proteinase K mutant with prolonged tolerance time to guanidine isothiocyanate in nucleic acid extraction lysate and application thereof | |
KR20070035499A (en) | Process for producing polypeptide | |
CN114381471A (en) | Application of auxiliary protein in recombinant protein production and fusion expression system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |